ASSERTIO THERAPEUTICS, INC. Finite-Lived Intangible Assets, Net
ASSERTIO THERAPEUTICS, INC. had Finite-Lived Intangible Assets, Net of $23.67 million as of 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2020-05-11
- 2020-03-31: Finite-Lived Intangible Assets, Net $23.67M.
- 2019-12-31: Finite-Lived Intangible Assets, Net $400.54M.
- 2019-09-30: Finite-Lived Intangible Assets, Net $615.77M.
- 2019-06-30: Finite-Lived Intangible Assets, Net $641.21M.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2020-03-31 | $23.67M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $400.54M 10-Q · filed 2020-05-11 |
| 2019-09-30 | $615.77M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $641.21M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $666.65M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $692.10M 10-K · filed 2020-03-10 |
| 2018-09-30 | $717.54M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $742.99M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $768.43M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $793.87M 10-K · filed 2019-03-11 |
| 2017-09-30 | $824.94M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $850.68M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $876.41M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $902.15M 10-K · filed 2018-03-01 |
| 2016-09-30 | $927.88M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $954.92M 10-Q · filed 2016-08-03 |
| 2016-03-31 | $981.96M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $1.01B 10-K · filed 2017-02-24 |
| 2015-09-30 | $1.04B 10-Q · filed 2015-11-09 |
| 2015-06-30 | $1.06B 10-Q · filed 2015-08-03 |
| 2014-12-31 | $72.36M 10-K · filed 2016-02-26 |